Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sheng

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Viral Hepatitis|March 28, 2017
Entecavir maleate versus entecavir in Chinese chronic hepatitis B predominantly genotype B or C: Results at week 144J-H Xu, S Wang, Z-N Xu, et al.
Journal of Viral Hepatitis|November 29, 2016
Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavirJ-H Xu, L-W Song, N Li, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2011
Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistanceJ Sun, J-L Hou, Q Xie, et al.
Journal of Viral Hepatitis|September 23, 2014
Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trialJ L Hou, Z L Gao, Q Xie, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 9, 2017
[Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C]B Feng, J Shang, S H Wu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 24, 2017
[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients]F Q Hou, Y L Yin, L Y Zeng, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Viral Hepatitis|March 28, 2017
Entecavir maleate versus entecavir in Chinese chronic hepatitis B predominantly genotype B or C: Results at week 144J-H Xu, S Wang, Z-N Xu, et al.
Journal of Viral Hepatitis|November 29, 2016
Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavirJ-H Xu, L-W Song, N Li, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2011
Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistanceJ Sun, J-L Hou, Q Xie, et al.
Journal of Viral Hepatitis|September 23, 2014
Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trialJ L Hou, Z L Gao, Q Xie, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 9, 2017
[Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C]B Feng, J Shang, S H Wu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 24, 2017
[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients]F Q Hou, Y L Yin, L Y Zeng, et al.
Pageof 6